An interventional study of SmartMom text messaging and Control text messaging in Pregnancy, sponsored by University of British Columbia. Recruiting at 1 site in Canada. Open to female participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-04.
Sponsored by University of British Columbia · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 156 studies in Psychological Well-Being with a site in Canada — 45 open to participants now, 59 under way, 1 of them phase 3. Psychological Well-Being · Canada.
Among the 156 studies in Psychological Well-Being with a site in Canada, this one is the 6th largest by planned enrollment of the 128 interventional ones that give a count, is one of 18 that started in 2023, is one of 120 with no phase, reaches primary completion later than 28 of the 58 other live ones, and was the 99th registered.
2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.
Browse Psychological Well-Being studies →45 of the 156 studies in Psychological Well-Being with a site in Canada are open now. Recruiting first, the newest first:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Sites in Canada
Ages 18+ · Women only · Healthy volunteers
The Hospital for Sick Children · Sites in Canada
Ages 8–17
The Hospital for Sick Children · Sites in Canada
Ages 10–17
Trillium Health Partners · Sites in Canada
Ages 14+ · Healthy volunteers
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Sites in Canada
Ages 16–35
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 403 Psychological Well-Being studies recruiting now, 223 (55%) set no upper age limit and 155 (38%) stop at 75 or younger; 121 take children under 18; 206 take healthy volunteers.
This study: 15 Years and older · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
156 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 18 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 3,078 is above the median of 110 across 1,808 interventional studies indexed under Psychological Well-Being.
Median enrollment 100 across the 128 interventional studies, 100 across the 27 observational. Of the 83 that completed or were terminated, 5 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 156 have an industry lead sponsor. The 10 most frequent:
University of British Columbia is the lead sponsor of 1,342 studies on the registry; 262 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
University of British Columbia has 9 studies filed under Psychological Well-Being — fewer than ten, so there is no comparison to draw.
18 of the studies in Psychological Well-Being with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07313657Bruyère Health Research Institute.Improving Care and Mental Well-Being for Adults With Heart Failure | 2026-11-30 |
| NCT05543720University Health Network, TorontoEvaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study | 2026-12 |
| NCT07867106Samuel Lunenfeld Research Institute, Mount Sinai HospitalPatient Experiences of Intraoperative Discomfort During Cesarean Delivery Under Neuraxial Anesthesia | 2026-12 |
| NCT06455397Leslie E. RoosBuilding Emotional Awareness and Mental Health (BEAM) 2024-2027 | 2026-12 |
| NCT05793944University of British ColumbiaSmartMom: Teaching by Texting to Promote Health Behaviours in Pregnancy | 2026-12-31 |
Add all 18 to your calendar (.ics) → With an account.
Among the 156 studies in Psychological Well-Being with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this randomized clinical trial is to evaluate the effectiveness of SmartMom, a text messaging-based mobile health program for prenatal education. The main questions are to determine if healthy pregnant people receiving SmartMom messages that promote health behaviours in pregnancy versus messages that don't provoke behaviour change have improvement in:
Participants in the intervention group will receive three evidence-based text messages per week, plus optional supplemental messages on topics relevant to them, throughout pregnancy.
The control group will receive general interest messages on pregnancy-related topics that are not promoting behaviour change.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants receive three text messages per week with evidence-based information to promote healthy behaviours during pregnancy.
Behavioral: SmartMom text messaging
Participants receive one text message per week with general information about pregnancy but not about making healthy choices.
Behavioral: Control text messaging
SmartMom is a mobile health program delivered via text messaging that guides participants through each week of pregnancy. Participants receive three messages per week with links to content focused on improving knowledge, providing information about prenatal assessments and screening, and encouraging the adoption of behaviours to support healthy pregnancy and physiologic birth. Messages are consistent with current professional guidelines and peer reviewed prenatal education curricula. SmartMom provides optional supplemental streams for individuals who wish to have additional messages addressing topics such as reducing use of tobacco, alcohol or illicit drugs, depression, obesity, and maternal age over 35.
Control arm participants will receive weekly text messages with accurate, general-interest information about pregnancy and about progress of the trial. Content is not geared to decision-making during pregnancy that may affect health outcomes.
Change in weight during pregnancy
Rate of pregnancy weight gain in a range appropriate for pre-pregnancy BMI. These include self-reported data as well as data from provincial prenatal registries and the Canadian Hospital Discharge Database linked via personal health number, provided as part of the consenting procedure.
Time frame: Enrollment, 38 weeks gestation
Attendance at prenatal care visits through pregnancy
Rates of attendance at prenatal care appointments in adherence to Canadian guidelines. These include self-reported data as well as data from provincial prenatal registries and the Canadian Hospital Discharge Database linked via personal health number, provided as part of the consenting procedure.
Time frame: 38 weeks gestation
Changes in health knowledge through pregnancy
Changes in health knowledge as measured by a 10-item knowledge test. Minimum score = 0, Maximum score = 10. Higher score indicates more knowledge i.e. more positive outcome.
Time frame: Enrollment, 38 weeks gestation
Health literacy at end of pregnancy
Health literacy as measured by self-report of i) information-seeking from local health and social services resources; ii) awareness of their choices regarding serum genetic screening; iii) awareness of their choices to have (yes/no) serum glucose screening.
Time frame: 38 weeks gestation
Changes in fear of childbirth through pregnancy
Changes in fear of childbirth as measured by The Childbirth Fear Scale, an 11-item, self-reported measure. Minimum score = 6, Maximum score = 66. Lower score means less fear, i.e. a more positive outcome.
Time frame: Enrollment, 38 weeks gestational age
Changes in depression through pregnancy
Changes in depression as measured by the Edinburgh Postnatal Depression Scale. This is a 10-item, self-report screening tool for postnatal depression that is also valid for use during pregnancy. Minimum score = 0. zero, Maximum score = 30. Lower score means less depression, i.e. a more positive outcome.
Time frame: Enrollment, 38 weeks gestational age
Changes in anxiety through pregnancy
Changes in anxiety as measured by the standardized 33-item Pregnancy Specific Anxiety Tool (PSAT). Minimum score = 6, Maximum score = 24. Lower score means less anxiety, i.e. a more positive outcome.
Time frame: Enrollment, 38 weeks gestational age
Changes in use of tobacco, vaping, alcohol, or cannabis through pregnancy among users.
Among participants indicating that they are users of tobacco, vaping, alcohol, and/or cannabis at enrollment, change of use at the end of pregnancy will be measured by self-report. Report: proportion of users that stopped using per trial arm. Among users continuing to use: mean change in number of daily cigarettes, episodes of vaping, drinks per week, cannabis products per day or other specified use of recreational or prescription drugs used per day.
Time frame: Enrollment, 38 weeks gestational age
Rates of planned vaginal birth after cesarean
Proportion of participants choosing to plan vaginal birth (VBAC) after a previous cesarean birth, among those deemed eligible by their caregivers. These include self-reported data as well as data from provincial prenatal registries and the Canadian Hospital Discharge Database linked via personal health number, provided as part of the consenting procedure.
Time frame: 38 weeks gestation
Rates of exclusive breastfeeding at hospital discharge
These include self-reported data as well as data from provincial prenatal registries and the Canadian Hospital Discharge Database linked via personal health number, provided as part of the consenting procedure.
Time frame: 1 month post birth
Rates of adverse pregnancy outcomes as measured by gestational diabetes, stillbirth, preterm birth (<37 weeks gestation) and small for gestational age (SGA) status at birth.
These include self-reported data as well as data from provincial prenatal registries and the Canadian Hospital Discharge Database linked via personal health number, provided as part of the consenting procedure.
Time frame: 1 month post birth
Incremental costs per incidence of suboptimal weight gain and inadequate prenatal care avoided.
Incremental costs per incidence of suboptimal weight gain and inadequate prenatal care avoided for the intervention group when compared to control group as an incremental cost-effectiveness ratio.
Time frame: Throughout pregnancy (up to 42 weeks) and birth, including hospital admission in which birth took place (up to 7 days).
Plan to share: Yes — Individual participant data will be available from the corresponding author upon reasonable request including a research proposal outlining how the data will be used and a certificate of ethical approval from an academic ethics review board.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: At completion of study enrollment for five years
Access criteria: Available to academic researchers who have submitted a research protocol that has been approved by a university ethics board.
Started Nov 2023 (actual). Primary completion is estimated for Dec 2026, 37 months after the start.
Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 37 months is above that.
Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of British Columbia →